These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17307639)

  • 1. Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease.
    Miheller P; Muzes G; Lakatos G; Mihály E; Tulassay Z
    J Emerg Med; 2007 Feb; 32(2):209-10; author reply 210. PubMed ID: 17307639
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum sickness-like reactions in patients receiving intravenous infliximab.
    Gamarra RM; McGraw SD; Drelichman VS; Maas LC
    J Emerg Med; 2006 Jan; 30(1):41-4. PubMed ID: 16434333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very late delayed-allergic reaction to natalizumab not associated with neutralizing antibodies.
    Killestein J; Jasperse B; Liedorp M; Seewann A; Polman Ch
    Mult Scler; 2009 Apr; 15(4):525-6. PubMed ID: 19324985
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab therapy in Crohn's disease: safety issues.
    Hommes DW; van Deventer SJ
    Neth J Med; 2003 Apr; 61(4):100-4. PubMed ID: 12852717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
    Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
    Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab.
    Moss AC; Treister NS; Marsee DK; Cheifetz AS
    Gastroenterology; 2007 Feb; 132(2):488, 829. PubMed ID: 17261307
    [No Abstract]   [Full Text] [Related]  

  • 7. Palmoplantar pustulosis and acrodermatitis in a patient treated with infliximab for Crohn's sacroiliitis.
    Wermuth J; Kind F; Steuerwald M
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):A28. PubMed ID: 19187898
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum sickness due to infliximab in a patient with psoriasis.
    Krishnan RS; Hsu S
    J Drugs Dermatol; 2004; 3(3):305-8. PubMed ID: 15176166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sickness associated with 6-mercaptopurine in a patient with Crohn's disease.
    Andersen JM; Tiede JJ
    Pharmacotherapy; 1997; 17(1):173-6. PubMed ID: 9017780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease.
    Sorrentino D; Terrosu G; Vadalà S; Avellini C
    Digestion; 2007; 75(1):22-4. PubMed ID: 17429204
    [No Abstract]   [Full Text] [Related]  

  • 11. First appearance of Crohn's disease following infliximab treatment for spondylarthropathy.
    Tsochatzis E; Vassilopoulos D; Manesis EK; Papatheodoridis G; Bousiotou A; Hadziyannis E; Archimandritis AJ
    Scand J Gastroenterol; 2007 Jun; 42(6):784-5. PubMed ID: 17506005
    [No Abstract]   [Full Text] [Related]  

  • 12. Timing infliximab therapy in pediatric Crohn's disease.
    Kirschner BS; Huo D
    Gastroenterology; 2007 Mar; 132(3):1167-70. PubMed ID: 17383435
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycobacterium marinum infection complicating Crohn's disease, treated with infliximab.
    Fallon JC; Patchett S; Gulmann C; Murphy GM
    Clin Exp Dermatol; 2008 Jan; 33(1):43-5. PubMed ID: 17983451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab-induced disseminated histoplasmosis in a patient with Crohn's disease.
    Galandiuk S; Davis BR
    Nat Clin Pract Gastroenterol Hepatol; 2008 May; 5(5):283-7. PubMed ID: 18398409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic vulval Crohn's disease and infliximab: a case report.
    Tritton SM; Whyte L; Fischer G
    J Reprod Med; 2009 Jan; 54(1):41-4. PubMed ID: 19263879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of premedication with intravenous corticosteroids and antihistaminics in preventing infusion reactions to infliximab].
    Bermejo F; López San Román A; Algaba A; van Domselaar M; Carneros JA; Rivero M; Piqueras B; Valer MP
    Gastroenterol Hepatol; 2008 Dec; 31(10):629-32. PubMed ID: 19174078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease.
    Steenholdt C; Svenson M; Bendtzen K; Thomsen OØ; Brynskov J; Ainsworth MA
    J Crohns Colitis; 2012 Feb; 6(1):108-11. PubMed ID: 22261535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed hypersensitivity reaction after initial dose of infliximab: a case report.
    Krajcovicova A; Hlavaty T; Zelinkova Z; Letkovsky J; Huorka M
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):485-7. PubMed ID: 24509644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated cutaneous varicella zoster virus infections during infliximab therapy for Crohn's disease: case report of two pediatric patients at one institution.
    Kunz AN; Rajnik M
    Clin Pediatr (Phila); 2011 Jun; 50(6):559-61. PubMed ID: 20837619
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
    Hyams J; Crandall W; Kugathasan S; Griffiths A; Olson A; Johanns J; Liu G; Travers S; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano R;
    Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.